assessment of patients skin dose undergoing coronary angiography and percutaneous transluminal coronary angioplasty (ptca)

Authors

m.b. tavakoli department of medical physics and medical engineering, school of medicine, isfahan university of medical sciences, isfahan, iran

s. monsef department of medical physics and medical engineering, school of medicine, isfahan university of medical sciences, isfahan, iran

m. hashemi department of internal medicine, school of medicine, isfahan university of medical sciences, isfahan, iran

h. emami department of radiation oncology, school of medicine, isfahan university of medical sciences, isfahan, iran

abstract

background: practice of interventional cardiology procedures such as coronary angiography (ca) and percutaneous transluminal coronary angioplasty (ptca) has largely increased in recent years and is now changing to a matter of routine in many hospitals. the purpose of this study was to measure skin and organ doses in patients undergoing ca and ptca and to find a probable relation with cardiologist's work experience. materials and methods: a group of 57 patients who were admitted to nour and chamran hospitals, isfahan, iran, either for ca (n=37) or ptca (n=20) was checked for skin, eyes and thyroid gland radiation dose. skin dose measurement was carried out with thermoluminescent dosimeters (tld-100) placed at three different positions on the patients' bodies. also the thyroid and eye doses were measured using the same procedure. results: mean median, standard deviation and maximum doses for these results are presented. maximum values found for skin in ca, ptca, thyroid gland and eyes were 41.00, 73.90, 3.10 and 1.43 cgy, respectively. average exposure time for ca and ptca was 4.2±2.6 and 10.8±8.2 minutes, respectively. radiation dose to the critical areas in each procedure in addition to its relation to the type of procedure was studied. correlation between maximum skin dose and cardiologists' work experience was also investigated. conclusion: 85% of the cases in ca and 78% of cases in ptca received maximum skin dose of lower than 25cgy well below the threshold of 2 gy suggestions for transient erythema. iran. j. radiat. res., 2010 8 (3): 155-160

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Assessment of patients skin dose undergoing coronary angiography and Percutaneous Transluminal Coronary Angioplasty (PTCA)

Background: Practice of interventional cardiology procedures such as Coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA) has largely increased in recent years and is now changing to a matter of routine in many hospitals. The purpose of this study was to measure skin and organ doses in patients undergoing CA and PTCA and to find a probable relation with c...

full text

[Percutaneous transluminal coronary angioplasty (PTCA)].

In 1959, Dr. Mason Sones reported on selective coronary arteriography, a technique that quickly became the standard for precise diagnosis of coronary artery disease. In the early 1960s Drs. Dotter and Judkins introduced the original concept of using a catheter to dilate an atherosclerotic obstruction in a peripheral artery. Now, almost 2 decades later, the selective coronary catheter is being p...

full text

Transluminal Coronary Angioplasty (PTCA)

Forty–six patients (21 with stable angina and 25 with chronic myocardial infarction, 37 men) with a total chronic proximal coronary occlusion and collateral vessels to the distal part of the occluded artery (30 LAD, 10 RCA and 6 CX properly distributed in both groups) were studied angiographically before and 2 to 8 months (mean 6) after balloon angioplasty. The patients were divided in six subg...

full text

Radiation doses to patients undergoing coronary angiography and percutaneous transluminal coronary angioplasty.

A detailed study of radiation doses received by 168 patients who underwent coronary angiography (CAG) and 102 patients who underwent percutaneous transluminal coronary angioplasty (PTCA) in two Greek hospitals is presented. Radiation dose was measured in terms of dose-area product (DAP). The contribution of fluoroscopy and cineradiography to the total DAP was examined separately for each radiol...

full text

Quality of Life in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA)

BACKGROUND Coronary artery diseases are the main causes of death in industrial Countries. Transluminal angioplasty is a common technique used to manage the condition of coronary arteries. The purpose of this study was to explore the quality of life in patients sustaining this measure in two stages before the procedure and then three consecutive after that 3, 6 and 12 months respectively. MATE...

full text

Percutaneous transluminal coronary angioplasty.

Percutaneous transluminal coronary angioplasty (PTCA) is a nonoperative mechanical dilatation of atherosclerotic coronary artery stenosis by a balloon-tipped dilating catheter system. This method can effectively reduce highly stenotic coronary lesions and provide early recovery of ischemic but viable myocardium. The technique of transluminal angioplasty was originally devised by Dotter and Judk...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of radiation research

جلد ۸، شماره ۳، صفحات ۱۵۵-۱۶۰

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023